Skip to content
Home › 13F recaps › Q3 2026 › ROIV

Which funds bought or sold ROIV in Q3 2026?

Roivant Sciences Ltd. 6 funds bought, 4 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$545M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold ROIV, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (6)

FundChangeEst. $Now
BlackRock
Index giant
Added+28.3%+$499M$2.3B
Jennison
Growth / crossover
Added+169.2%+$277M$441M
Farallon
Hedge fund
Added+52%+$272M$795M
State Street
Index giant
Added+25.9%+$168M$819M
Legal & General
Asset manager
Added+128.6%+$34M$60M
Viking
Hedge fund
Added+7.7%+$18M$247M

Sold (4)

FundChangeEst. $Now
Goldman Sachs
Bank & broker
Trimmed-77.4%−$526M$153M
QRT
Quant & multi-strategy
Sold out−$122M—
DME / Greenlight
Value investor
Trimmed-47.4%−$37M$41M
Maverick
Hedge fund
Trimmed-18.4%−$19M$84M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.